Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation

Purpose - To evaluate diagnostic performance and inter-reader agreement of the Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET). - Methods - This retrospective, multi-center study included patients who underwent high-intensity focused ultrasound (HIFU...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ehrengut, Constantin (VerfasserIn) , Alberalar, Nilüfer Deniz (VerfasserIn) , Franz, Toni (VerfasserIn) , Horn, Lars-Christian (VerfasserIn) , Blana, Andreas (VerfasserIn) , Hadaschik, Boris (VerfasserIn) , Stolzenburg, Jens-Uwe (VerfasserIn) , Schlemmer, Heinz-Peter (VerfasserIn) , Ebel, Sebastian (VerfasserIn) , Denecke, Timm (VerfasserIn) , Ganzer, Roman (VerfasserIn) , Schaudinn, Alexander (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2026
In: European journal of radiology
Year: 2026, Jahrgang: 195, Pages: 1-7
ISSN:1872-7727
DOI:10.1016/j.ejrad.2025.112572
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejrad.2025.112572
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0720048X25006588
Volltext
Verfasserangaben:Constantin Ehrengut, Nilüfer Deniz Alberalar, Toni Franz, Lars-Christian Horn, Andreas Blana, Boris Hadaschik, Jens-Uwe Stolzenburg, Heinz Peter Schlemmer, Sebastian Ebel, Timm°Denecke, Roman Ganzer, Alexander Schaudinn

MARC

LEADER 00000naa a2200000 c 4500
001 1963203798
003 DE-627
005 20260302115240.0
007 cr uuu---uuuuu
008 260302s2026 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejrad.2025.112572  |2 doi 
035 |a (DE-627)1963203798 
035 |a (DE-599)KXP1963203798 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ehrengut, Constantin  |e VerfasserIn  |0 (DE-588)139170665X  |0 (DE-627)1963204506  |4 aut 
245 1 0 |a Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation  |c Constantin Ehrengut, Nilüfer Deniz Alberalar, Toni Franz, Lars-Christian Horn, Andreas Blana, Boris Hadaschik, Jens-Uwe Stolzenburg, Heinz Peter Schlemmer, Sebastian Ebel, Timm°Denecke, Roman Ganzer, Alexander Schaudinn 
264 1 |c February 2026 
300 |b Illustrationen 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 24. November 2025, Artikelversion: 29. November 2025 
500 |a Gesehen am 02.03.2026 
520 |a Purpose - To evaluate diagnostic performance and inter-reader agreement of the Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET). - Methods - This retrospective, multi-center study included patients who underwent high-intensity focused ultrasound (HIFU) hemiablation for localized prostate cancer (PCa), with follow-up multiparametric MRI (mpMRI) at 12 months and subsequent biopsy (reference standard). Three radiologists independently assessed the mpMRIs using the TARGET score (treated prostate side) and the PI-RADS score (v2.1, untreated side). Diagnostic performance metrics and area under the receiver operating characteristic curves (AUC) were computed for any-/clinically significant-PCa (cs-PCa) and two scoring thresholds (3 vs. 4). Inter-reader-agreement was analyzed using Fleiss к. - Results - Of all 40 patients included, 23 had biopsy-proven recurrent PCa in 26 lesions, with seven lesions harboring cs-PCa (5/7 on the treated side). TARGET showed moderate to high sensitivity (Reader 1-3: 60-100 %), high NPV (91-100 %) but lower specificity (54-69 %) and PPV (16-27 %) in the detection of cs-PCa, given a scoring threshold of ≥ 3. The diagnostic performance for cs-PCa (AUC: 0.57-0.79) exceeded that of any-PCa (0.54-0.64). PI-RADS showed an overall moderate efficacy in any-/cs-PCa-detection (untreated prostate side, AUC: 0.52-0.60). Overall inter-reader agreement was moderate (TARGET к = 0.60-0.64, PI-RADS к = 0.54-0.55). - Conclusions - The strength of the TARGET score was its high NPV, implying its potential to rule out cs-PCa. However, the moderate sensitivity and specificity, low PPV and moderate inter-reader agreement indicate a limited reliability of TARGET to consistently identify cs-PCa recurrence. The generalizability of these findings is restricted by the overall small sample size. 
650 4 |a Focal therapy 
650 4 |a Hemiablation 
650 4 |a HIFU 
650 4 |a Multiparametric MRI 
650 4 |a Prostate cancer 
650 4 |a TARGET 
700 1 |a Alberalar, Nilüfer Deniz  |e VerfasserIn  |4 aut 
700 1 |a Franz, Toni  |e VerfasserIn  |4 aut 
700 1 |a Horn, Lars-Christian  |e VerfasserIn  |4 aut 
700 1 |a Blana, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Hadaschik, Boris  |e VerfasserIn  |4 aut 
700 1 |a Stolzenburg, Jens-Uwe  |e VerfasserIn  |4 aut 
700 1 |a Schlemmer, Heinz-Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1025559967  |0 (DE-627)722927142  |0 (DE-576)17334805X  |4 aut 
700 1 |a Ebel, Sebastian  |e VerfasserIn  |4 aut 
700 1 |a Denecke, Timm  |e VerfasserIn  |4 aut 
700 1 |a Ganzer, Roman  |e VerfasserIn  |4 aut 
700 1 |a Schaudinn, Alexander  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of radiology  |d Amsterdam [u.a.] : Elsevier Science, 1990  |g 195(2026) vom: Feb., Artikel-ID 112572, Seite 1-7  |h Online-Ressource  |w (DE-627)32044483X  |w (DE-600)2005350-2  |w (DE-576)099718138  |x 1872-7727  |7 nnas  |a Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation 
773 1 8 |g volume:195  |g year:2026  |g month:02  |g elocationid:112572  |g pages:1-7  |g extent:7  |a Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation 
856 4 0 |u https://doi.org/10.1016/j.ejrad.2025.112572  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0720048X25006588  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260302 
993 |a Article 
994 |a 2026 
998 |g 1025559967  |a Schlemmer, Heinz-Peter  |m 1025559967:Schlemmer, Heinz-Peter  |d 50000  |e 50000PS1025559967  |k 0/50000/  |p 8 
999 |a KXP-PPN1963203798  |e 4926309947 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"February 2026","dateIssuedKey":"2026"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Constantin Ehrengut, Nilüfer Deniz Alberalar, Toni Franz, Lars-Christian Horn, Andreas Blana, Boris Hadaschik, Jens-Uwe Stolzenburg, Heinz Peter Schlemmer, Sebastian Ebel, Timm°Denecke, Roman Ganzer, Alexander Schaudinn"]},"person":[{"family":"Ehrengut","display":"Ehrengut, Constantin","given":"Constantin","role":"aut"},{"display":"Alberalar, Nilüfer Deniz","given":"Nilüfer Deniz","role":"aut","family":"Alberalar"},{"display":"Franz, Toni","role":"aut","given":"Toni","family":"Franz"},{"role":"aut","given":"Lars-Christian","display":"Horn, Lars-Christian","family":"Horn"},{"display":"Blana, Andreas","role":"aut","given":"Andreas","family":"Blana"},{"display":"Hadaschik, Boris","role":"aut","given":"Boris","family":"Hadaschik"},{"family":"Stolzenburg","given":"Jens-Uwe","role":"aut","display":"Stolzenburg, Jens-Uwe"},{"display":"Schlemmer, Heinz-Peter","given":"Heinz-Peter","role":"aut","family":"Schlemmer"},{"family":"Ebel","role":"aut","given":"Sebastian","display":"Ebel, Sebastian"},{"family":"Denecke","display":"Denecke, Timm","role":"aut","given":"Timm"},{"family":"Ganzer","role":"aut","given":"Roman","display":"Ganzer, Roman"},{"family":"Schaudinn","display":"Schaudinn, Alexander","given":"Alexander","role":"aut"}],"language":["eng"],"title":[{"title":"Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation","title_sort":"Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation"}],"recId":"1963203798","id":{"doi":["10.1016/j.ejrad.2025.112572"],"eki":["1963203798"]},"relHost":[{"language":["eng"],"pubHistory":["Nachgewiesen 10.1990 -"],"origin":[{"dateIssuedKey":"1990","dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"7","year":"2026","text":"195(2026) vom: Feb., Artikel-ID 112572, Seite 1-7","volume":"195","pages":"1-7"},"title":[{"title":"European journal of radiology","subtitle":"EJR","title_sort":"European journal of radiology"}],"titleAlt":[{"title":"EJR"}],"id":{"zdb":["2005350-2"],"issn":["1872-7727"],"eki":["32044483X"]},"recId":"32044483X","disp":"Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablationEuropean journal of radiology","note":["Gesehen am 05.02.20"],"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Online verfügbar: 24. November 2025, Artikelversion: 29. November 2025","Gesehen am 02.03.2026"],"physDesc":[{"extent":"7 S.","noteIll":"Illustrationen"}]} 
SRT |a EHRENGUTCOEVALUATION2026